Literature DB >> 31197256

KDM2B promotes IL-6 production and inflammatory responses through Brg1-mediated chromatin remodeling.

Qingqing Zhou1, Yunkai Zhang2, Bo Wang1, Wenhui Zhou1, Yong Bi3, Wanwan Huai4, Xi Chen4, Yihan Chen5, Zhongmin Liu1, Xingguang Liu6, Zhenzhen Zhan7,8.   

Abstract

IL-6 plays important and pleiotropic roles in infection and inflammatory diseases, and its production needs to be tightly regulated. However, the epigenetic mechanism underlying Il6 gene transcription remains to be fully elucidated. Here, we report that lysine-specific demethylase 2b (KDM2B), which demethylates H3K4me3 and H3K36me2, is required in macrophages and dendritic cells for the induction of IL-6 but not TNF-α, IL-1, and IFN-β. Compared to wild-type mice, KDM2B-deficient mice were more resistant to endotoxin shock and colitis, with a less severe inflammatory pathogenesis phenotype and decreased IL-6 production in sera. KDM2B selectively bound the Il6 promoter but did not alter histone demethylation; instead, KDM2B interacted with Brahma-related gene 1 (Brg1), the core ATPase subunit of SWI/SNF chromatin remodeling complexes, to facilitate chromatin accessibility of the Il6 promoter. Furthermore, KDM2B directly recruited RNA Polymerase II to further initiate and promote Il6 transcription. Thus, our finding identifies a novel nonclassical function of KDM2B in gene-specific transcription initiation and enhancement of Il6 independent of its demethylase activity and adds new insight into the specific epigenetic modification mechanism of inflammatory immune responses.

Entities:  

Keywords:  Brg1; Chromatin remodeling; IL-6; Inflammation; KDM2B

Year:  2019        PMID: 31197256      PMCID: PMC7395766          DOI: 10.1038/s41423-019-0251-z

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  6 in total

1.  OTUD6A promotes prostate tumorigenesis via deubiquitinating Brg1 and AR.

Authors:  Xuhong Fu; Junjie Zhao; Guopeng Yu; Xiaomin Zhang; Jie Sun; Lingmeng Li; Jingyi Yin; Yinan Niu; Shancheng Ren; Yasheng Zhu; Bin Xu; Liyu Huang
Journal:  Commun Biol       Date:  2022-03-01

Review 2.  Targeting epigenetic regulators for inflammation: Mechanisms and intervention therapy.

Authors:  Su Zhang; Yang Meng; Lian Zhou; Lei Qiu; Heping Wang; Dan Su; Bo Zhang; Kui-Ming Chan; Junhong Han
Journal:  MedComm (2020)       Date:  2022-09-15

Review 3.  Epigenome-metabolome-microbiome axis in health and IBD.

Authors:  Hajera Amatullah; Kate L Jeffrey
Journal:  Curr Opin Microbiol       Date:  2020-09-10       Impact factor: 7.934

4.  Transcriptomic Profiling of Skeletal Muscle Reveals Candidate Genes Influencing Muscle Growth and Associated Lipid Composition in Portuguese Local Pig Breeds.

Authors:  André Albuquerque; Cristina Óvilo; Yolanda Núñez; Rita Benítez; Adrián López-Garcia; Fabián García; Maria do Rosário Félix; Marta Laranjo; Rui Charneca; José Manuel Martins
Journal:  Animals (Basel)       Date:  2021-05-16       Impact factor: 2.752

5.  KDM2B overexpression prevents myocardial ischemia-reperfusion injury in rats through regulating inflammatory response via the TLR4/NF-κB p65 axis.

Authors:  Zijie Wei; Lihua Luo; Shuo Hu; Rongcheng Tian; Ziyou Liu
Journal:  Exp Ther Med       Date:  2021-12-17       Impact factor: 2.447

6.  PP2Cδ Controls the Differentiation and Function of Dendritic Cells Through Regulating the NSD2/mTORC2/ACLY Pathway.

Authors:  Nianyin Lv; Sufeng Jin; Zihao Liang; Xiaohui Wu; Yanhua Kang; Lan Su; Yeping Dong; Bingwei Wang; Tonghui Ma; Liyun Shi
Journal:  Front Immunol       Date:  2022-01-07       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.